简体中文 | 繁體中文 | English

Press Releases

2020-02-06 14:32 MSCI Launches Solution Enabling Investors to Assess Exposure to Climate Risk
2020-02-06 14:24 Takeda Demonstrates Business Momentum, Accelerated Integration Synergies, and Raises FY2019 Guidance Including Positive Reported Operating Profit
2020-02-06 11:56 WELL Hits Major Global Milestone Supporting Healthier People and Better Buildings
2020-02-06 10:03 Zynga Announces Fourth Quarter and Full Year 2019 Financial Results
2020-02-06 09:58 Euromonitor Launches Via: A New Pricing Intelligence Solution
2020-02-06 09:54 CORRECTING and REPLACING InterSystems Wins Two 2020 Best in KLAS Awards
2020-02-06 09:44 BORN Group and Fluent Commerce Announce Global Partnership to Help Retailers Worldwide Manage Orders More Efficiently
2020-02-05 17:39 Jefferies Announces The Jefferies Asia Forum 2020
2020-02-05 17:22 Velodyne Lidar Appoints Mathew Rekow as New CTO
2020-02-05 16:19 Leucadia Asset Management Announces Strategic Relationship with Dymon Asia Capital
2020-02-05 16:12 T-Mobile CZ and Slovak Telekom Have Selected Mavenir for Their Next-Generation NFV-Based Harmonized IMS
2020-02-05 16:06 Professional Triathletes Organisation Approaches Wanda Sports Renewing Interest in Ironman Acquisition and Expressing Willingness to Work With Other Potential Acquirers
2020-02-05 15:38 teamLab Planets, a “Museum Where You Walk through Water” in Tokyo, Is Transformed by Cherry Blossoms for a Limited Time This Spring. On View from March 1, 2020.
2020-02-05 15:05 GSMA Updated Statement on Coronavirus
2020-02-05 14:08 ABB: Full-Year and Q4 2019 Results
2020-02-05 11:46 Global Enterprises and Merchants Unprepared as Fraudsters Focus on Rewards Programs
2020-02-05 11:30 Solid Sphere Inc.: Original Kuso App for Smartphones Takeshobo Quest - POP TEAM EPIC ASSAULTS
2020-02-05 10:13 PTW Appoints New Chief Operating Officer and Chief Product Officer to Executive Team
2020-02-05 10:06 TNS Managed Hosting Solution Now Live at HKEX Hosting Data Center
2020-02-05 10:01 Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660